DrugPatentWatch Database Preview

RENESE Drug Profile

  Purchase this report

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Renese, and when can generic versions of Renese launch?

Renese is a drug marketed by Pfizer and is included in two NDAs.

The generic ingredient in RENESE is polythiazide; reserpine. There is one drug master file entry for this compound. Additional details are available on the polythiazide; reserpine profile page.

Summary for RENESE

US Patents:	0
Applicants:	1
NDAs:	2
Bulk Api Vendors:	18
Patent Applications:	2,767
Formulation / Manufacturing:	see details
DailyMed Link:	RENESE at DailyMed

Synonyms for RENESE

2-Methyl-3-(beta,beta,beta-trifluoroethylthiomethyl)-6-chloro-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide

2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3,4-dihydro-2-methyl-3-(((2,2,2-trifluoroethyl)thio)methyl)-, 1,1-dioxide

2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3,4-dihydro-2-methyl-3-(((2,2,2-trifluoroethyl)thio)methyl)-, 1,1-dioxide (8CI, 9CI)

2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3,4-dihydro-2-methyl-3-[[(2,2,2-trifluoroethyl)thio]methyl]-, 1,1-dioxide

2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3,4-dihydro-2-methyl-3-[[(2,2,2-trifluoroethyl)thio]methyl]-, 1,1-dioxide (8CI, 9CI)

2H-1,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3,4-dihydro-2-methyl-3-[[(2,2,2-trifluoroethyl)thio]methyl]-, 1,1-dioxide

346-18-9

6-chloro-2-methyl-1,1-dioxo-3-(2,2,2-trifluoroethylsulfanylmethyl)-3,4-dihydro-1

6-chloro-2-methyl-1,1-dioxo-3-(2,2,2-trifluoroethylsulfanylmethyl)-3,4-dihydro-1?^{6},2,4-benzothiadiazine-7-sulfonamide

6-chloro-2-methyl-1,1-dioxo-3-(2,2,2-trifluoroethylsulfanylmethyl)-3,4-dihydrobenzo[e][1,2,4]thiadiazine-7-sulfonamide

6-chloro-2-methyl-1,1-dioxo-3-{[(2,2,2-trifluoroethyl)sulfanyl]methyl}-3,4-dihydro-2H-1$l;{6},2,4-benzothiadiazine-7-sulfonamide

6-Chloro-2-methyl-3-([(2,2,2-trifluoroethyl)sulfanyl]methyl)-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide #

6-CHLORO-2-METHYL-3-[[(2,2,2-TRIFLUOROETHYL)SULFANYL]METHYL]-3,4-DIHYDRO-2H-1,2,4-BENZOTHIADIAZINE-7-SULFONAMIDE 1,1-DIOXIDE

6-chloro-2-methyl-3-{[(2,2,2-trifluoroethyl)thio]methyl}-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide

6-Chloro-3,2,2-trifluoroethyl)thio]methyl]-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide

6-Chloro-3,4-dihydro-2-methyl-3-(((2,2,2-trifluoroethyl)thio)methyl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide

6-Chloro-3,4-dihydro-2-methyl-3-[[(2,2,2-trifluoroethyl)thio]methyl]-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide

6-Chloro-3,4-dihydro-2-methyl-7-sulphamoyl-3-(2,2,2-trifluoroethylthiomethyl)-2H-benzo-1,2,4-thiadiazine 1,1-dioxide

AC1L1J55

AC1Q6TPT

ACM346189

API0006930

BRN 0770371

C07766

C11H13ClF3N3O4S3

CAS-346-18-9

CCRIS 6094

CHEBI:8327

CHEMBL1587

CYLWJCABXYDINA-UHFFFAOYSA-N

D00657

D06TNG

DB01324

Drenusil

DSSTox_CID_5939

DSSTox_GSID_25939

DSSTox_RID_77972

EINECS 206-468-4

FT-0673974

GTPL7274

HE068604

HE337049

HSDB 850

KS-1466

LS-1223

NCGC00182076-02

NCGC00182076-03

Nephril

NSC 108161

NSC-108161

NSC108161

P 2525

P-2525

Politiazida

Politiazida [INN-Spanish]

polythiazide

POLYTHIAZIDE (200 MG)

Polythiazide (JAN/USAN/INN)

Polythiazide [USAN:INN:BAN:JAN]

Polythiazidum

Polythiazidum [INN-Latin]

Renese (TN)

SCHEMBL27909

SR-01000883970

SR-01000883970-1

Tox21_113137

Tox21_113137_1

WLN: T66 BSWN EM DHJ C1 D1S1XFFF HG ISZW

US Patents and Regulatory Information for RENESE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Pfizer	RENESE	polythiazide	TABLET;ORAL	012845-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Pfizer	RENESE-R	polythiazide; reserpine	TABLET;ORAL	013636-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Pfizer	RENESE	polythiazide	TABLET;ORAL	012845-002	Approved Prior to Jan 1, 1982		DISCN	No	No
Pfizer	RENESE	polythiazide	TABLET;ORAL	012845-003	Approved Prior to Jan 1, 1982		DISCN	No	No

  Purchase this report

see a sample report or, see our see our flat-rate plans

  Purchase this report

see a sample report or, see our see our flat-rate plans